TGF-β, TGF-β receptor II and TGF-β-activated kinase 1 (TAK1) are upregulated in HNSCC and result in constitutive hyper-activation of NF-κB with increased cell proliferation, migration, and invasion [188]. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.